Vivos Therapeutics, Inc. (VVOS) Revenue 2019–2025
Vivos Therapeutics, Inc. (VVOS) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$17.4MFY2025 · since FY2019: $11.4M → $17.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.4M | +16.0% |
| FY2024 | $15.0M | +8.9% |
| FY2023 | $13.8M | -13.9% |
| FY2022 | $16.0M | -5.1% |
| FY2021 | $16.9M | +29.2% |
| FY2020 | $13.1M | +14.7% |
| FY2019 | $11.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice